-
Patient VoicesRead stories about cancer and treatment from the people who are living through it.
-
Survivor Profile
Educator and AdvocateFormer teacher Peggy Zuckerman helps others by sharing her experiences with stage IV kidney cancer.
by Kristin Baird Rattini
-
Q&A
Cancer’s Public PersonaElaine Schattner explores how public discourse has shaped our perception of cancer.
by Marci A Landsmann
-
Facts and Stats
Know the LingoMedical paperwork can be full of confusing jargon. Use these definitions to better understand the terms found in your pathology report.
by Thomas Celona
-
Q&A
Tangled Family TiesSusan Keller’s best hope at keeping cancer at bay meant tracking down a brother who didn’t want to be found.
by Marci A. Landsmann
-
Survivor Profile
The Power of PersistenceAlbert Khoury’s determination to explore all treatment options for his rare lung cancer led to a lifesaving transplant surgery.
by Thomas Celona
-
A Personal Journey of Thyroid Cancer TreatmentThe practical side of cancer treatment and life without a thyroid.
by Carly Flumer
-
Survivor Profile
Rising to the ChallengeJames R. Scott uses his experiences with bladder cancer to be a light for others.
by Lindsey Konkel Neabore
-
My Name is Mom. And I Have Cancer.Author Tara Rolle shares the challenge of staying fully present as a parent during cancer treatment and in the years that followed.
by Tara Rolle
-
Finding Your NicheSupport groups offer community for people with cancer in a world that doesn’t understand their experience.
by Carly Flumer
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
